Dr. Daniel S. Jones, M.D.
Internal Medicine (Internal Medicine Physician)
9850 Genesee Ave Ste 780
La Jolla, CA 92037
Who else practices at this address →
San Diego County includes primary care (1% of residents) and mental health (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Jefferson Medical College of Thomas Jefferson University (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 157
Licensed in California since 2008, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: Jefferson Medical College of Thomas Jefferson University
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
CA license A102945 (first issued 2008; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Scripps Memorial Hospital La Jolla La Jolla, CA
- Scripps Mercy Hospital San Diego, CA
Medical groups
- Scripps Health Inpatient Providers Medical Group Inc (214 clinicians)
- La Jolla Pulmonary and Critical Care Inc (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 157
- Services billed
- 468
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 222 | 89 |
| Established patient office or other outpatient visit, 30-39 minutes | 84 | 39 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 72 | 49 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 41 | 25 |
| Established patient office or other outpatient visit, 20-29 minutes | 13 | 12 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in La Jolla, CA | 93 |
| Eliquis (apixaban) Other prescribers in La Jolla, CA | 20 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in La Jolla, CA | 19 |
| Fasenra Pen (benralizumab) | 14 |
| Pantoprazole Sodium Other prescribers in La Jolla, CA | 14 |
| Budesonide-Formoterol Fumarate (budesonide/formoterol fumarate) Other prescribers in La Jolla, CA | 13 |
| Pirfenidone | 13 |
| Prednisone Other prescribers in La Jolla, CA | 12 |
| Bumetanide Other prescribers in La Jolla, CA | 11 |
| Montelukast Sodium Other prescribers in La Jolla, CA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 43 payments worth $1,457 in total to this clinician.
| Getinge USA Sales, LLC | $489 |
|---|---|
| Grifols USA, LLC | $158 |
| Insmed, Inc. | $149 |
| Haemonetics Corporation | $145 |
| Genzyme Corporation | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $116 |
| Verona Pharma, Inc. | $43.11 |
| AstraZeneca Pharmaceuticals LP | $41.97 |
| Food and Beverage | $969 |
|---|---|
| Travel and Lodging | $489 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Getinge USA Sales, LLC Apr 28, 2025 | Travel and Lodging VASOVIEW HEMOPRO 2 · CARDIOVASCULAR CARE · travel to ATLANTA, GA | $489 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $78,466 in research payments for these studies, mostly to the institutions running them.
- Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
United Therapeutics Corporation · Recruiting · NCT05943535 - Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmon…
AstraZeneca Pharmaceuticals LP - A prospective cohort study of patients with refractory or unexplained
GlaxoSmithKline, LLC.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.